This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


A growing body of scientific evidence supports the potential effectiveness of collagen peptides in bolstering joint structure and function. This Whitepaper by Rousselot examines the mechanisms of action behind Peptan®, the company’s collagen peptide for joint health applications.

  • Inflammation of the joint or synovium may play an active role in contributing to joint issues.
  • Wear and tear on cartilage tissues can make joints more susceptible to damage and distress.
  • Collagen peptides have shown chondroprotective, chondroregenerative and anti-inflammatory effects.